Effects of SFRP4 overexpression on the production of adipokines in transgenic mice

References

• Collaborators GBDO, Afshin A, Forouzanfar MH, et al. Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med. 2017;377(1):13–27.
   PubMed Web of Science ®Google Scholar
• Harris MI, Flegal KM, Cowie CC, et al. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The third national health and nutrition examination survey, 1988-1994. Diabetes Care. 1998;21(4):518–524.
   PubMed Web of Science ®Google Scholar
• Harris MI. Diabetes in America: epidemiology and scope of the problem. Diabetes Care. 1998;21(Suppl 3):C11–4.
   PubMed Web of Science ®Google Scholar
• Rasouli N, Kern PA. Adipocytokines and the metabolic complications of obesity. J Clin Endocrinol Metab. 2008;93(11 Suppl 1):S64–73.
   PubMed Web of Science ®Google Scholar
• Nicholson T, Church C, Baker DJ, et al. The role of adipokines in skeletal muscle inflammation and insulin sensitivity. J Inflamm (Lond). 2018;15:9.
   PubMed Web of Science ®Google Scholar
• Trayhurn P, Wood IS. Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr. 2004;92(3):347–355.
   PubMed Web of Science ®Google Scholar
• Conde J, Scotece M, Gómez R, et al. Adipokines: biofactors from white adipose tissue. A complex hub among inflammation, metabolism, and immunity. Biofactors. 2011;37(6):413–420.
   PubMed Web of Science ®Google Scholar
• Pawar NM, Rao P. Secreted frizzled related protein 4 (sFRP4) update: A brief review. Cell Signal. 2018;45:63–70.
   PubMed Web of Science ®Google Scholar
• Ehrlund A, Mejhert N, Lorente-Cebrián S, et al. Characterization of the Wnt inhibitors secreted frizzled-related proteins (SFRPs) in human adipose tissue. J Clin Endocrinol Metab. 2013;98(3):E503–8.
   PubMed Web of Science ®Google Scholar
• Christodoulides C, Lagathu C, Sethi JK, et al. Adipogenesis and WNT signalling. Trends Endocrinol Metab. 2009;20(1):16–24.
   PubMed Web of Science ®Google Scholar
• Ross SE, Hemati N, Longo KA, et al. Inhibition of adipogenesis by Wnt signaling. Science. 2000;289(5481):950–953.
   PubMed Web of Science ®Google Scholar
• Prestwich TC, Macdougald OA. Wnt/beta-catenin signaling in adipogenesis and metabolism. Curr Opin Cell Biol. 2007;19(6):612–617.
   PubMed Web of Science ®Google Scholar
• Huang A, Huang Y. Role of Sfrps in cardiovascular disease. Ther Adv Chronic Dis. 2020;11:2040622320901990.
   Web of Science ®Google Scholar
• Zeng W, Cao Y, Jiang W, et al. Knockdown of Sfrp4 attenuates apoptosis to protect against myocardial ischemia/reperfusion injury. J Pharmacol Sci. 2019;140(1):14–19.
   PubMed Web of Science ®Google Scholar
• Mahdi T, Hänzelmann S, Salehi A, et al. Secreted frizzled-related protein 4 reduces insulin secretion and is overexpressed in type 2 diabetes. Cell Metab. 2012;16(5):625–633.
   PubMed Web of Science ®Google Scholar
• Muley A, Majumder S, Kolluru GK, et al. Secreted frizzled-related protein 4: an angiogenesis inhibitor. Am J Pathol. 2010;176(3):1505–1516.
   PubMed Web of Science ®Google Scholar
• Sandsmark E, Andersen MK, Bofin AM, et al. SFRP4 gene expression is increased in aggressive prostate cancer. Sci Rep. 2017;7(1):14276.
   PubMedGoogle Scholar
• Nakanishi R, Akiyama H, Kimura H, et al. Osteoblast-targeted expression of Sfrp4 in mice results in low bone mass. J Bone Miner Res. 2008;23(2):271–277.
   PubMed Web of Science ®Google Scholar
• Park JR, Jung J-W, Lee Y-S, et al. The roles of Wnt antagonists Dkk1 and sFRP4 during adipogenesis of human adipose tissue-derived mesenchymal stem cells. Cell Prolif. 2008;41(6):859–874.
   PubMed Web of Science ®Google Scholar
• Bukhari SA, Yasmin A, Zahoor MA, et al. Secreted frizzled-related protein 4 and its implication in obesity and type-2 diabetes. IUBMB Life. 2019;71(11):1701–1710.
   PubMed Web of Science ®Google Scholar
• Horbelt T, Knebel B, Fahlbusch P, et al. The adipokine sFRP4 induces insulin resistance and lipogenesis in the liver. Biochim Biophys Acta Mol Basis Dis. 2019;1865(10):2671–2684.
   PubMed Web of Science ®Google Scholar
• Anand K, Vidyasagar S, Lasrado I, et al. Secreted Frizzled-Related Protein 4 (SFRP4): A novel biomarker of beta-cell dysfunction and insulin resistance in individuals with prediabetes and type 2 diabetes. Diabetes Care. 2016;39(9):e147–8.
   PubMed Web of Science ®Google Scholar
• Garufi G, Seyhan AA, Pasarica M. Elevated secreted frizzled-related protein 4 in obesity: a potential role in adipose tissue dysfunction. Obesity (Silver Spring). 2015;23(1):24–27.
   PubMed Web of Science ®Google Scholar
• Bergmann K, Sypniewska G. Secreted frizzled-related protein 4 (SFRP4) and fractalkine (CX3CL1) - Potential new biomarkers for beta-cell dysfunction and diabetes. Clin Biochem. 2014;47(7–8):529–532.
   PubMed Web of Science ®Google Scholar
• Guan H, Zhang Y, Gao S, et al. Differential patterns of secreted frizzled-related protein 4 (SFRP4) in adipocyte differentiation: adipose depot specificity. Cell Physiol Biochem. 2018;46(5):2149–2164.
   PubMedGoogle Scholar
• Gao S, Wang X, Cheng D, et al. Overexpression of cholesteryl ester transfer protein increases macrophage-derived foam cell accumulation in atherosclerotic lesions of transgenic rabbits. Mediators Inflamm. 2017;2017:3824276.
   PubMed Web of Science ®Google Scholar
• Zhao S, Li Y, Gao S, et al. Autocrine human urotensin II enhances macrophage-derived foam cell formation in transgenic rabbits. Biomed Res Int. 2015;2015:843959.
   PubMed Web of Science ®Google Scholar
• Fan J, Wang J, Bensadoun A, et al. Overexpression of hepatic lipase in transgenic rabbits leads to a marked reduction of plasma high density lipoproteins and intermediate density lipoproteins. Proc Natl Acad Sci U S A. 1994;91(18):8724–8728.
   PubMed Web of Science ®Google Scholar
• Chen Y, Waqar AB, Nishijima K, et al. Macrophage-derived MMP-9 enhances the progression of atherosclerotic lesions and vascular calcification in transgenic rabbits. J Cell Mol Med. 2020; 24(7):4261–4274.
   Web of Science ®Google Scholar
• Wang W, Chen Y, Bai L, et al. Transcriptomic analysis of the liver of cholesterol-fed rabbits reveals altered hepatic lipid metabolism and inflammatory response. Sci Rep. 2018;8(1):6437.
   PubMedGoogle Scholar
• Parlee SD,Lentz SI, Mori H, MacDougald OA. Quantifying size and number of adipocytes in adipose tissue. Methods Enzymol. 2014;537:93–122.
   PubMed Web of Science ®Google Scholar
• Yue F, Cheng Y, Breschi A, et al. A comparative encyclopedia of DNA elements in the mouse genome. Nature. 2014;515(7527):355–364.
   PubMed Web of Science ®Google Scholar
• Mastaitis J, Eckersdorff M, Min S, et al. Loss of SFRP4 alters body size, food intake, and energy expenditure in diet-induced obese male mice. Endocrinology. 2015;156(12):4502–4510.
   PubMed Web of Science ®Google Scholar
• Engfeldt P, Arner P. Lipolysis in human adipocytes, effects of cell size, age and of regional differences. Horm Metab Res. 1988;19:26–29.
   Google Scholar
• Despres JP, Fong BS, Julien P, et al. Regional variation in HDL metabolism in human fat cells: effect of cell size. Am J Physiol. 1987;252(5 Pt 1):E654–9.
   PubMedGoogle Scholar
• Weyer C, Foley JE, Bogardus C, et al. Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts type II diabetes independent of insulin resistance. Diabetologia. 2000;43(12):1498–1506.
   PubMed Web of Science ®Google Scholar
• Fang L, Guo F, Zhou L, et al. The cell size and distribution of adipocytes from subcutaneous and visceral fat is associated with type 2 diabetes mellitus in humans. Adipocyte. 2015;4(4):273–279.
   PubMed Web of Science ®Google Scholar
• Yang J, Eliasson B, Smith U, et al. The size of large adipose cells is a predictor of insulin resistance in first-degree relatives of type 2 diabetic patients. Obesity (Silver Spring). 2012;20(5):932–938.
   PubMed Web of Science ®Google Scholar
• Hoffmann MM, Werner C, Böhm M, et al. Association of secreted frizzled-related protein 4 (SFRP4) with type 2 diabetes in patients with stable coronary artery disease. Cardiovasc Diabetol. 2014;13:155.
   PubMed Web of Science ®Google Scholar
• Verboven K, Wouters K, Gaens K, et al. Abdominal subcutaneous and visceral adipocyte size, lipolysis and inflammation relate to insulin resistance in male obese humans. Sci Rep. 2018;8(1):4677.
   PubMedGoogle Scholar
• Achari AE, Jain SK. Adiponectin, a therapeutic target for obesity, diabetes, and endothelial dysfunction. Int J Mol Sci. 2017;18(6):1321.
   PubMed Web of Science ®Google Scholar
• Esteve E, Ricart W, Fernandez-Real JM. Adipocytokines and insulin resistance: the possible role of lipocalin-2, retinol binding protein-4, and adiponectin. Diabetes Care. 2009;32(Suppl 2):S362–7.
   PubMed Web of Science ®Google Scholar
• Combs TP, Pajvani UB, Berg AH, et al. A transgenic mouse with a deletion in the collagenous domain of adiponectin displays elevated circulating adiponectin and improved insulin sensitivity. Endocrinology. 2004;145(1):367–383.
   PubMed Web of Science ®Google Scholar
• Nawrocki AR, Rajala MW, Tomas E, et al. Mice lacking adiponectin show decreased hepatic insulin sensitivity and reduced responsiveness to peroxisome proliferator-activated receptor gamma agonists. J Biol Chem. 2006;281(5):2654–2660.
   PubMed Web of Science ®Google Scholar
• Maeda N, Shimomura I, Kishida K, et al. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med. 2002;8(7):731–737.
   PubMed Web of Science ®Google Scholar
• Huang S, Czech MP. The GLUT4 glucose transporter. Cell Metab. 2007;5(4):237–252.
   PubMed Web of Science ®Google Scholar
• Stenbit AE, Tsao T-S, Li J, et al. GLUT4 heterozygous knockout mice develop muscle insulin resistance and diabetes. Nat Med. 1997;3(10):1096–1101.
   PubMed Web of Science ®Google Scholar
• Gregoire FM, Smas CM, Sul HS. Understanding adipocyte differentiation. Physiol Rev. 1998;78(3):783–809.
   PubMed Web of Science ®Google Scholar
• Ntambi JM, Young-Cheul K. Adipocyte differentiation and gene expression. J Nutr. 2000;130(12):3122S–3126S.
   PubMed Web of Science ®Google Scholar
• Wang QA, Tao C, Gupta RK, et al. Tracking adipogenesis during white adipose tissue development, expansion and regeneration. Nat Med. 2013;19(10):1338–1344.
   PubMed Web of Science ®Google Scholar
• Longo M, Zatterale F, Naderi J, et al. Adipose tissue dysfunction as determinant of obesity-associated metabolic complications. Int J Mol Sci. 2019;20(9):2358.
   Web of Science ®Google Scholar
• Hamdy O, Porramatikul S, Al-Ozairi E. Metabolic obesity: the paradox between visceral and subcutaneous fat. Curr Diabetes Rev. 2006;2(4):367–373.
   PubMedGoogle Scholar
• Yeh WC, Cao Z, Classon M, et al. Cascade regulation of terminal adipocyte differentiation by three members of the C/EBP family of leucine zipper proteins. Genes Dev. 1995;9(2):168–181.
   PubMed Web of Science ®Google Scholar
• Chen M-H, Tong Q. An update on the regulation of adipogenesis. Drug Discov Today Dis Mech. 2013;10(1–2):e15–e19.
   Google Scholar
• Loftus TM, Lane MD. Modulating the transcriptional control of adipogenesis. Curr Opin Genet Dev. 1997;7(5):603–608.
   PubMed Web of Science ®Google Scholar
• Cao Z, Umek RM, McKnight SL. Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells. Genes Dev. 1991;5(9):1538–1552.
   PubMed Web of Science ®Google Scholar
• Tanaka T, Yoshida N, Kishimoto T, Akira S. Defective adipocyte differentiation in mice lacking the C/EBPbeta and/or C/EBPdelta gene. Embo J. 1997;16(24):7432–7443.
   PubMed Web of Science ®Google Scholar